Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

IVUS Optimized Left Main 2-Stent Strategy: Should We Drop the 5-6-7-8 Criterion?

Provisional stenting in bifurcations has shown better results at mid and long term vs initial two stent strategy, according to Bifurcation Club consensus. However, approximately 22% of patients initially treated with provisional stenting require a second stent.

Studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) such as the EXCEL and NOBLE, have indicated that between 35% and 50% of patients undergoing complex PCI will receive two stents. Therefore, it is vital to adequately optimize PCI to treat these lesions with this technique. 

The use of intravascular imaging, such as IVUS, has been shown superior to conventional angiography when it comes to major adverse cardiovascular events (MACE). A prior study run by the Asan Medical Center research group proposed the 5-6-7-8 criterion to evaluate optimal minimal stent area (MSA) in left main PCI. However, this study included a heterogeneous population (72% with a single stent and 28% with two stents) and assessed restenosis within brief 9 months. 

The aim of this study run by Kim et al. was to review IVUS derived MSA cutoff values to establish optimal stent expansion in patients undergoing crush technique for left main treatment, at 5 year follow-up. 

Read also: Edge-to-Edge Tricuspid Valve Repair 3-Year Follow Up.

It included patients with left main compromise receiving crushing with two stents in one center in Seoul, South Korea. Stent and post dilation balloon selection was based on IVUS outcomes. The following segments were assessed by IVUS: anterior descending ostium, 5 mm distal to the carina; circumflex ostium, 5 mm distal to the carina; and the left main distal segment. 

Primary end point at 5 years was MACE, defined as a composite of all-cause mortality, lesion related acute myocardial infarction and clinically driven target lesion revascularization.  

292 patients were included, mean age 64 ± 9.9 years; 76.7% were men and 33.6% were diabetic. Only 6.8% of patients presented an acute event upon admission. The main branch used average 1.5 ± 0.7 stents (mean 28.0 ± 6.1 mm length and 3.7 ± 0.4 mm diameter), while the side branch used 1.1 ± 0.4 stents (21.8 ± 7.1 mm length and 3.0 ± 0.3 mm diameter).

MSA values for MACE prediction at 5 years were 11.8 mm² for distal left main (area under the curve- AUC, 0.57 [95% CI, 0.48–0.67]; P=0.15), 8.3 mm² for the anterior descending ostium (AUC, 0.62 [95% CI, 0.54–0.71]; P=0.02) and 5.7 mm² for the circumflex ostium (AUC, 0.64 [95% CI, 0.55–0.74]; P=0.01). Using these criteria, we observed that 64.7% of distal left main, 55.1% of anterior descending ostia and 48.3% of circumflex ostia presented underexpansion.

Read also: Should We Withdraw Anticoagulation Before TAVR?

The most significant MACE predictor was anterior descending and circumflex ostium underexpansion (HR, 3.14 [CI 95%, 1.23–8.06]; P=0.02), not distal left main, which was not associated to prognosis. Compared against a group with adequate expansion, patients with combined anterior descending and circumflex underexpansion presented five times higher MACE (HR 5.49 [95% CI, 2.10–14.3]; P<0.001) and significantly higher mortality rates (HR, 7.11 [CI 95%, 1.40–36.1]; P=0.018).

Conclusions

This study on IVUS in left main two stenting has shown that ≤8.3 mm² MSA in the anterior descending ostium, and ≤5.7 mm² in the circumflex ostium is associated with significantly increased MACE risk at 5 years. Therefore, optimizing PCI using these IVUS parameters is crucial.

Original Title: Optimal Minimal Stent Area and Impact of Stent Underexpansion in Left Main Up-Front 2-Stent Strategy. 

Reference: Kim JH, Kang DY, Ahn JM, Kweon J, Choi Y, Kim H, Lee J, Chae J, Kang SJ, Park DW, Park SJ. Optimal Minimal Stent Area and Impact of Stent Underexpansion in Left Main Up-Front 2-Stent Strategy. Circ Cardiovasc Interv. 2024 Jan;17(1):e013006. doi: 10.1161/CIRCINTERVENTIONS.123.013006. Epub 2024 Jan 16. PMID: 38227699.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Omar Tupayachi
Dr. Omar Tupayachi
Member of the Editorial Board of solaci.org

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

HERA-TAVI: Intra-Annular vs Supra-Annular Valves in TAVI

The HERA-TAVI study is an international multicenter registry that compared the clinical and hemodynamic outcomes of contemporary self-expanding transcatheter heart valves with intra-annular (IA)...

DOUBLE-CHOICE: Lower Pacemaker Implantation Rates with ACURATE neo2 Compared with Evolut in Patients Undergoing TAVI

The DOUBLE-CHOICE trial is a multicenter, randomized, controlled study conducted in Germany to evaluate the performance of next-generation transcatheter heart valves and different anesthesia...

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...